Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Net Worth 2006-2019 | GILD

Interactive chart of historical net worth (market cap) for Gilead Sciences (GILD) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Gilead Sciences net worth as of April 09, 2020 is $94.41B.
  
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $94.414B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $128.832B 14.78
CSL (CSLLY) Australia $89.311B 0.00
Vertex Pharmaceuticals (VRTX) United States $64.729B 58.74
Regeneron Pharmaceuticals (REGN) United States $56.366B 23.87
Biogen (BIIB) United States $55.170B 9.42
Illumina (ILMN) United States $41.306B 42.70
Alexion Pharmaceuticals (ALXN) United States $21.890B 10.15
Seattle Genetics (SGEN) United States $20.641B 0.00
Incyte (INCY) United States $19.022B 40.81
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.901B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.322B 612.31
Genmab (GMAB) Denmark $14.121B 10.96
Genmab (GNMSF) Denmark $13.202B 42.46
Galapagos (GLPG) Belgium $13.109B 40.06
Alnylam Pharmaceuticals (ALNY) United States $12.595B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.850B 55.38
Moderna (MRNA) United States $10.666B 0.00
BioNTech SE (BNTX) Germany $10.170B 0.00
Exact Sciences (EXAS) United States $9.821B 0.00
BeiGene (BGNE) Cayman Islands $9.145B 0.00
QIAGEN (QGEN) Netherlands $8.994B 27.42
Sarepta Therapeutics (SRPT) United States $8.079B 0.00
Bio-Techne Corp (TECH) United States $7.632B 52.23
ACADIA Pharmaceuticals (ACAD) United States $6.649B 0.00
Guardant Health (GH) United States $6.091B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.993B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.937B 15.69
Ascendis Pharma (ASND) Denmark $5.823B 0.00
Exelixis (EXEL) United States $5.689B 18.26
Repligen (RGEN) United States $5.026B 91.90
Acceleron Pharma (XLRN) United States $4.588B 0.00
Reata Pharmaceuticals (RETA) United States $4.566B 0.00
China Biologic Products (CBPO) China $4.200B 24.93
Immunomedics (IMMU) United States $3.943B 0.00
Global Blood Therapeutics (GBT) United States $3.791B 0.00
Blueprint Medicines (BPMC) United States $3.621B 0.00
Mirati Therapeutics (MRTX) United States $3.435B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.375B 0.00
MorphoSys AG (MOR) Germany $3.251B 0.00
Emergent Biosolutions (EBS) United States $3.220B 22.36
Zai Lab (ZLAB) China $3.202B 0.00
Vir Biotechnology (VIR) United States $3.195B 0.00
Adaptive Biotechnologies (ADPT) United States $3.162B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.069B 0.00
NeoGenomics (NEO) United States $2.749B 119.18
CRISPR Therapeutics AG (CRSP) Switzerland $2.702B 45.75
Amicus Therapeutics (FOLD) United States $2.580B 0.00
Alkermes (ALKS) Ireland $2.498B 197.88
Deciphera Pharmaceuticals (DCPH) United States $2.478B 0.00
Halozyme Therapeutics (HALO) United States $2.442B 0.00
Arena Pharmaceuticals (ARNA) United States $2.403B 6.26
Bluebird Bio (BLUE) United States $2.394B 0.00
UniQure (QURE) Netherlands $2.391B 0.00
MyoKardia (MYOK) United States $2.336B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.203B 0.00
Amarin (AMRN) Ireland $2.075B 0.00
Principia Biopharma (PRNB) United States $2.028B 0.00
Denali Therapeutics (DNLI) United States $1.968B 0.00
Fate Therapeutics (FATE) United States $1.946B 0.00
Alector (ALEC) United States $1.835B 0.00
Eidos Therapeutics (EIDX) United States $1.805B 0.00
Epizyme (EPZM) United States $1.696B 0.00
Arvinas (ARVN) United States $1.694B 0.00
Zymeworks (ZYME) Canada $1.659B 0.00
Insmed (INSM) United States $1.649B 0.00
Viela Bio (VIE) United States $1.589B 0.00
Akcea Therapeutics (AKCA) United States $1.588B 34.15
Dicerna Pharmaceuticals (DRNA) United States $1.401B 0.00
Ligand Pharmaceuticals (LGND) United States $1.370B 42.57
Inovio Pharmaceuticals (INO) United States $1.214B 0.00
REGENXBIO (RGNX) United States $1.170B 0.00
Coherus BioSciences (CHRS) United States $1.166B 13.82
Zealand Pharma (ZEAL) Denmark $1.157B 0.00
Editas Medicine (EDIT) United States $1.131B 0.00
PHARMA MAR SA (PHMMF) Spain $1.073B 0.00
Myriad Genetics (MYGN) United States $1.063B 18.76
NGM Biopharmaceuticals (NGM) United States $1.019B 0.00
NextCure (NXTC) United States $0.995B 0.00
Twist Bioscience (TWST) United States $0.972B 0.00
Intra-Cellular Therapies (ITCI) United States $0.944B 0.00
Novavax (NVAX) United States $0.885B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.864B 0.00
Beam Therapeutics (BEAM) United States $0.857B 0.00
Adverum Biotechnologies (ADVM) United States $0.855B 0.00
Sangamo Therapeutics (SGMO) United States $0.811B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.807B 0.00
Cytokineticsorporated (CYTK) United States $0.759B 0.00
I-Mab (IMAB) China $0.747B 0.00
Arcus Biosciences (RCUS) United States $0.704B 0.00
Athenex (ATNX) United States $0.680B 0.00
Retrophin (RTRX) United States $0.674B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Cara Therapeutics (CARA) United States $0.658B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.634B 0.00
Kadmon Holdings (KDMN) United States $0.630B 0.00
GENFIT S.A (GNFT) France $0.624B 0.00
Codexis (CDXS) United States $0.622B 0.00
Mesoblast (MESO) Australia $0.614B 0.00
Intellia Therapeutics (NTLA) United States $0.610B 0.00
Bellus Health (BLU) Canada $0.608B 0.00
Compugen (CGEN) Israel $0.600B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.585B 5.14
ZIOPHARM Oncology Inc (ZIOP) United States $0.564B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.547B 0.00
ANI Pharmaceuticals (ANIP) United States $0.535B 9.64
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.511B 0.00
Clovis Oncology (CLVS) United States $0.509B 0.00
Castle Biosciences (CSTL) United States $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.488B 0.00
Athersys (ATHX) United States $0.488B 0.00
Heska (HSKA) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.473B 12.07
Vericel (VCEL) United States $0.467B 69.33
Frequency Therapeutics (FREQ) United States $0.467B 0.00
DBV Technologies S.A (DBVT) France $0.466B 0.00
Verastem (VSTM) United States $0.465B 0.00
Intrexon (PGEN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Scholar Rock Holding (SRRK) United States $0.452B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.445B 0.00
Sorrento Therapeutics (SRNE) United States $0.444B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Cue Biopharma (CUE) United States $0.441B 0.00
Anika Therapeutics (ANIK) United States $0.438B 15.08
Cel-Sci (CVM) United States $0.432B 0.00
Mersana Therapeutics (MRSN) United States $0.428B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
Morphic Holding (MORF) United States $0.418B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.406B 0.00
Cellectis S.A (CLLS) France $0.402B 0.00
MiMedx (MDXG) United States $0.398B 0.00
AnaptysBio (ANAB) United States $0.396B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 44.89
CytomX Therapeutics (CTMX) United States $0.383B 0.00
Agenus (AGEN) United States $0.378B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.366B 0.00
PDL BioPharma (PDLI) United States $0.361B 10.81
Kala Pharmaceuticals (KALA) United States $0.342B 0.00
Merus (MRUS) Netherlands $0.325B 0.00
Syros Pharmaceuticals (SYRS) United States $0.308B 0.00
Pfenex (PFNX) United States $0.308B 449.50
Puma Biotechnology (PBYI) United States $0.303B 0.00
Cellular Biomedicine (CBMG) United States $0.300B 0.00
Precision BioSciences (DTIL) United States $0.298B 0.00
NantKwest (NK) United States $0.291B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.284B 0.00
Kamada (KMDA) Israel $0.280B 11.65
Syndax Pharmaceuticals (SNDX) United States $0.276B 0.00
Dynavax Technologies (DVAX) United States $0.276B 0.00
WAVE Life Sciences (WVE) Singapore $0.268B 0.00
Avid Bioservices (CDMO) United States $0.265B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.259B 0.00
Gritstone Oncology (GRTS) United States $0.248B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.246B 0.00
Albireo Pharma (ALBO) United States $0.245B 0.00
Stemline Therapeutics (STML) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Seres Therapeutics (MCRB) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
MannKind (MNKD) United States $0.219B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
Geron (GERN) United States $0.216B 0.00
Alcobra (ARCT) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Prometic Life Sciences (LMNL) Canada $0.206B 0.00
Abeona Therapeutics (ABEO) United States $0.198B 0.00
Starpharma Holdings (SPHRY) Australia $0.196B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.195B 1.75
XOMA (XOMA) United States $0.190B 0.00
Protagonist Therapeutics (PTGX) United States $0.188B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.178B 0.00
HOOKIPA Pharma (HOOK) United States $0.171B 0.00
IVERIC Bio (ISEE) United States $0.170B 0.00
VBI Vaccines (VBIV) United States $0.169B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Liquidia Technologies (LQDA) United States $0.163B 0.00
OSMOTICA PHARM (OSMT) United States $0.163B 0.00
Exicure (XCUR) United States $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.152B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Fortress Biotech (FBIO) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Affimed (AFMD) Germany $0.149B 0.00
VolitionRX (VNRX) United States $0.148B 0.00
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
Cerecor (CERC) United States $0.139B 0.00
Aytu Bioscience (AYTU) United States $0.138B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.132B 0.00
Theratechnologies (THTX) Canada $0.128B 0.00
AIT Therapeutics (XAIR) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.126B 0.00
VTv Therapeutics (VTVT) United States $0.125B 0.00
Celyad SA (CYAD) Belgium $0.116B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.114B 4.47
Enzo Biochem (ENZ) United States $0.113B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.105B 0.00
Strongbridge Biopharma (SBBP) United States $0.103B 0.00
Aptinyx (APTX) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.099B 0.00
TELA Bio (TELA) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.097B 2.63
PHASEBIO PHARMA (PHAS) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Five Prime Therapeutics (FPRX) United States $0.089B 0.00
IBio (IBIO) United States $0.089B 0.00
CorMedix Inc (CRMD) United States $0.087B 0.00
Pluristem Therapeutics (PSTI) Israel $0.087B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.079B 0.00
Cyclerion Therapeutics (CYCN) United States $0.078B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.077B 4.52
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Eton Pharmaceuticals (ETON) United States $0.076B 0.00
Happiness Biotech Group (HAPP) China $0.076B 0.00
Arbutus Biopharma (ABUS) Canada $0.070B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
Adocia (ADOCY) France $0.066B 0.00
Vaccinex (VCNX) United States $0.065B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.060B 0.00
SESEN BIO, INC (SESN) United States $0.060B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.059B 0.00
Synlogic (SYBX) United States $0.057B 0.00
AquaBounty Technologies (AQB) United States $0.055B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Trevena (TRVN) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Acorda Therapeutics (ACOR) United States $0.047B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Idera Pharmaceuticals (IDRA) United States $0.045B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
Advaxis (ADXS) United States $0.042B 0.00
CollPlant Holdings (CLGN) Israel $0.037B 0.00
Protalix BioTherapeutics (PLX) Israel $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Soligenix (SNGX) United States $0.035B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.032B 0.00
Celsion (CLSN) United States $0.030B 0.00
Prima BioMed (IMMP) Australia $0.029B 0.00
Evogene (EVGN) Israel $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Menlo Therapeutics (MNLO) United States $0.026B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Curis (CRIS) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.022B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Alimera Sciences (ALIM) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Apricus Biosciences (SEEL) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
VIVUS (VVUS) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
Aptevo Therapeutics (APVO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00